Antitumoral effect in mice of a new triepoxyde derivative: 1, 3, 5-triglycidyl-s-triazinetrione (NSC 296934).
D000284:Administration, Oral; D000818:Animals; D004334:Drug Administration Schedule; D005260:Female; D007274:Injections, Intraperitoneal; D007928:Lethal Dose 50; D007942:Leukemia, Experimental / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D014227:Triazines / Q000627:therapeutic use*
D014227:Triazines; C028786:teroxirone